← Open Payments lookup

SARAH KO: Open Payments

NPI 1336699933 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$16,120 in 106 payments from 13 companies in 2025. Trend: 2023 $2,148 · 2024 $13,719 · 2025 $16,120

Speaker / faculty: $13,334Food & beverage: $2,536Education: $211Travel & lodging: $39
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.51$14,636
Janssen Pharmaceuticals, Inc12$367
Alkermes, Inc.10$226
Neurocrine BioSciences, Inc.7$217
E.R. Squibb & Sons, L.L.C.6$177
Otsuka America Pharmaceutical, Inc.7$163
ABBVIE INC.5$133
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$52
Supernus Pharmaceuticals, Inc.2$42
Stryker Corporation1$31

Products named: UZEDY, AUSTEDO XR, ARISTADA, INGREZZA, SPRAVATO, INVEGA SUSTENNA, COBENFY, VRAYLAR.

Industry payments across CA — which companies pay providers there.